awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q34095789-03D4F83A-08A3-4982-A777-0410A72B9E7B
Q34095789-03D4F83A-08A3-4982-A777-0410A72B9E7B
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34095789-03D4F83A-08A3-4982-A777-0410A72B9E7B
Experience in Phase I Trials and an Upcoming Phase II Study with uPA Inhibitors in Metastatic Breast Cancer.
P2860
Q34095789-03D4F83A-08A3-4982-A777-0410A72B9E7B
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34095789-03D4F83A-08A3-4982-A777-0410A72B9E7B
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
a331158aafd6247b91955c88854c796fd844ee4a
P2860
Prognostic impact of proteolytic factors (urokinase-type plasminogen activator, plasminogen activator inhibitor 1, and cathepsins B, D, and L) in primary breast cancer reflects effects of adjuvant systemic therapy.